Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ratiopharm up for grabs

This article was originally published in The Tan Sheet

Executive Summary

The Merckle Group, the parent of German OTC and generic drug firm Ratiopharm, agrees with investors at VEM VV GmbH to arrange for a bridge loan from Merckle's creditor banks in order to sell Ratiopharm. The Jan. 7 decision follows the suicide of Merckle Group founder, Adolf Merckle, which was linked to his and the company's financial crises. The sale likely will take several months, Ratiopharm says
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS102490

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel